Dallah Healthcare Past Earnings Performance
Past criteria checks 5/6
Dallah Healthcare has been growing earnings at an average annual rate of 23.7%, while the Healthcare industry saw earnings growing at 11.9% annually. Revenues have been growing at an average rate of 21.4% per year. Dallah Healthcare's return on equity is 11.1%, and it has net margins of 12.2%.
Key information
23.7%
Earnings growth rate
22.1%
EPS growth rate
Healthcare Industry Growth | 12.3% |
Revenue growth rate | 21.4% |
Return on equity | 11.1% |
Net Margin | 12.2% |
Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
We Ran A Stock Scan For Earnings Growth And Dallah Healthcare (TADAWUL:4004) Passed With Ease
Apr 16What You Can Learn From Dallah Healthcare Company's (TADAWUL:4004) P/E
Mar 18Returns On Capital At Dallah Healthcare (TADAWUL:4004) Have Hit The Brakes
Feb 25Dallah Healthcare (TADAWUL:4004) Has More To Do To Multiply In Value Going Forward
Oct 30Dallah Healthcare (TADAWUL:4004) Is Reinvesting At Lower Rates Of Return
Jul 26Returns On Capital Signal Tricky Times Ahead For Dallah Healthcare (TADAWUL:4004)
Apr 17Is Now The Time To Put Dallah Healthcare (TADAWUL:4004) On Your Watchlist?
Feb 06Dallah Healthcare (TADAWUL:4004) Will Want To Turn Around Its Return Trends
Dec 05We Ran A Stock Scan For Earnings Growth And Dallah Healthcare (TADAWUL:4004) Passed With Ease
Nov 01Calculating The Intrinsic Value Of Dallah Healthcare Company (TADAWUL:4004)
Aug 28Dallah Healthcare (TADAWUL:4004) Has Some Way To Go To Become A Multi-Bagger
Aug 12Here's Why We Think Dallah Healthcare (TADAWUL:4004) Is Well Worth Watching
Jul 28Industry Analysts Just Upgraded Their Dallah Healthcare Company (TADAWUL:4004) Revenue Forecasts By 10%
May 26Calculating The Fair Value Of Dallah Healthcare Company (TADAWUL:4004)
May 20Here's Why We Think Dallah Healthcare (TADAWUL:4004) Is Well Worth Watching
Apr 16Dallah Healthcare (TADAWUL:4004) Might Be Having Difficulty Using Its Capital Effectively
Feb 03Is Now The Time To Put Dallah Healthcare (TADAWUL:4004) On Your Watchlist?
Jan 10Dallah Healthcare (TADAWUL:4004) Might Be Having Difficulty Using Its Capital Effectively
Oct 19Dallah Healthcare (TADAWUL:4004) Might Be Having Difficulty Using Its Capital Effectively
Jul 09Forecast: Analysts Think Dallah Healthcare Company's (TADAWUL:4004) Business Prospects Have Improved Drastically
Jun 16Broker Revenue Forecasts For Dallah Healthcare Company (TADAWUL:4004) Are Surging Higher
May 02What Kind Of Shareholders Hold The Majority In Dallah Healthcare Company's (TADAWUL:4004) Shares?
Mar 17Has Dallah Healthcare (TADAWUL:4004) Got What It Takes To Become A Multi-Bagger?
Mar 02Dallah Healthcare (TADAWUL:4004) Shareholders Booked A 45% Gain In The Last Year
Feb 15Should You Buy Dallah Healthcare Company (TADAWUL:4004) For Its Dividend?
Feb 01Are Dallah Healthcare's (TADAWUL:4004) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Jan 05Dallah Healthcare Company's (TADAWUL:4004) Intrinsic Value Is Potentially 26% Below Its Share Price
Dec 22Will Dallah Healthcare (TADAWUL:4004) Multiply In Value Going Forward?
Nov 20Are Dividend Investors Getting More Than They Bargained For With Dallah Healthcare Company's (TADAWUL:4004) Dividend?
Jul 13Revenue & Expenses BreakdownBeta
How Dallah Healthcare makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 2,943 | 360 | 549 | 0 |
30 Sep 23 | 2,831 | 325 | 537 | 0 |
30 Jun 23 | 2,682 | 270 | 509 | 0 |
31 Mar 23 | 2,595 | 286 | 477 | 0 |
31 Dec 22 | 2,488 | 274 | 443 | 0 |
30 Sep 22 | 2,370 | 305 | 464 | 0 |
30 Jun 22 | 2,313 | 311 | 450 | 0 |
31 Mar 22 | 2,220 | 289 | 434 | 0 |
31 Dec 21 | 2,105 | 259 | 416 | 0 |
30 Sep 21 | 1,935 | 202 | 402 | 0 |
30 Jun 21 | 1,742 | 206 | 371 | 0 |
31 Mar 21 | 1,498 | 165 | 331 | 0 |
31 Dec 20 | 1,318 | 132 | 307 | 0 |
30 Sep 20 | 1,257 | 150 | 277 | 0 |
30 Jun 20 | 1,207 | 123 | 272 | 0 |
31 Mar 20 | 1,246 | 131 | 287 | 0 |
31 Dec 19 | 1,252 | 147 | 286 | 0 |
30 Sep 19 | 1,227 | 110 | 304 | 0 |
30 Jun 19 | 1,206 | 115 | 295 | 0 |
31 Mar 19 | 1,193 | 119 | 293 | 0 |
31 Dec 18 | 1,181 | 142 | 286 | 0 |
30 Sep 18 | 1,189 | 172 | 281 | 0 |
30 Jun 18 | 1,203 | 217 | 274 | 0 |
31 Mar 18 | 1,218 | 268 | 260 | 0 |
31 Dec 17 | 1,212 | 295 | 246 | 0 |
30 Sep 17 | 1,202 | 284 | 254 | 0 |
30 Jun 17 | 1,180 | 268 | 265 | 0 |
31 Mar 17 | 1,181 | 252 | 275 | 0 |
31 Dec 16 | 1,163 | 225 | 288 | 0 |
30 Sep 16 | 1,122 | 228 | 264 | 0 |
30 Jun 16 | 1,073 | 194 | 255 | 0 |
31 Mar 16 | 1,030 | 175 | 249 | 0 |
31 Dec 15 | 985 | 165 | 231 | 0 |
30 Sep 15 | 948 | 161 | 219 | 0 |
30 Jun 15 | 917 | 156 | 211 | 0 |
31 Mar 15 | 892 | 154 | 206 | 0 |
31 Dec 14 | 859 | 147 | 201 | 0 |
30 Sep 14 | 831 | 149 | 203 | 0 |
30 Jun 14 | 805 | 149 | 194 | 0 |
31 Mar 14 | 773 | 138 | 184 | 0 |
31 Dec 13 | 750 | 137 | 182 | 0 |
30 Sep 13 | 718 | 119 | 172 | 0 |
30 Jun 13 | 693 | 121 | 163 | 0 |
Quality Earnings: 4004 has high quality earnings.
Growing Profit Margin: 4004's current net profit margins (12.2%) are higher than last year (11%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 4004's earnings have grown significantly by 23.7% per year over the past 5 years.
Accelerating Growth: 4004's earnings growth over the past year (31.2%) exceeds its 5-year average (23.7% per year).
Earnings vs Industry: 4004 earnings growth over the past year (31.2%) exceeded the Healthcare industry 20.5%.
Return on Equity
High ROE: 4004's Return on Equity (11.1%) is considered low.